Dominika Dziadosz

Katowice, SL, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Prevalence, clinical significance, and risk factors of arrhythmic mitral valve prolapse - results of the MITPROL AR-PL Registry.

Prevalence, clinical significance, and risk factors of arrhythmic mitral valve prolapse - results of the MITPROL AR-PL Registry.

Journal: Kardiologia polska

Published: July 15, 2026

Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786.

Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786.

Journal: Diagnostics (Basel, Switzerland)

Published: March 23, 2026

Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function.

Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function.

Journal: Diagnostics (Basel, Switzerland)

Published: January 29, 2026

Rationale, objectives, and design of the multicenter observational study - Mitral Valve Prolapse by Echocardiography and Arrhythmia (MITPROL AR-PL).

Rationale, objectives, and design of the multicenter observational study - Mitral Valve Prolapse by Echocardiography and Arrhythmia (MITPROL AR-PL).

Journal: Kardiologia polska

Published: July 04, 2025

Misfortune never comes singly: an unusual case of a patient with type 1 diabetes mellitus and widespread cardiac fibrosis with restrictive phenotype, mitral stenosis, and postcapillary pulmonary hypertension.

Misfortune never comes singly: an unusual case of a patient with type 1 diabetes mellitus and widespread cardiac fibrosis with restrictive phenotype, mitral stenosis, and postcapillary pulmonary hypertension.

Journal: Polish archives of internal medicine

Published: November 05, 2024

What Do We Know So Far About Ventricular Arrhythmias and Sudden Cardiac Death Prediction in the Mitral Valve Prolapse Population? Could Biomarkers Help Us Predict Their Occurrence?

What Do We Know So Far About Ventricular Arrhythmias and Sudden Cardiac Death Prediction in the Mitral Valve Prolapse Population? Could Biomarkers Help Us Predict Their Occurrence?

Journal: Current cardiology reports

Published: February 22, 2024

Clinical Application of the HCM-AF Risk Score in the Prediction of Clinical Outcomes of Polish Patients with Hypertrophic Cardiomyopathy.

Clinical Application of the HCM-AF Risk Score in the Prediction of Clinical Outcomes of Polish Patients with Hypertrophic Cardiomyopathy.

Journal: Journal of clinical medicine

Published: June 10, 2023

'A series of unfortunate events': a case report of infective endocarditis resulting from ventricular arrhythmia ablation.

'A series of unfortunate events': a case report of infective endocarditis resulting from ventricular arrhythmia ablation.

Journal: European heart journal. Case reports

Published: December 29, 2022

Inter-Specialty Controversies on the Treatment of Cardiovascular Diseases during Pregnancy: A Questionnaire Study.

Inter-Specialty Controversies on the Treatment of Cardiovascular Diseases during Pregnancy: A Questionnaire Study.

Journal: Medicina (Kaunas, Lithuania)

Published: November 24, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026